We integrated clinical parameters including PSA, tumor volume, and age with the risk scores estimated from classifiers (Cbr, CΔr, and Cbcl) to develop integrated classifiers CΔrbcl, CΔrbcl, and CΔrΔcl for predicting AS+. This evidence concerns the gene KLK3 and neoplasm.